× Medicines Discovery Catapult

Secure the funding you need to evaluate the commercial potential of your ideas.

We’re looking for SMEs and academics with the ingenuity to develop the best healthcare technology to partner with for the Biomedical Catalyst 2019 round 1: feasibility and primer awards.


UK businesses can apply for a share of up to £3 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.

Closes: 3rd April 2019
Organisation: Innovate UK
Guidelines: Read the full competition details >

Why partner with Medicines Discovery Catapult?

  • We can help push your projects towards commercial viability, with access to our teams connections –  across industry, academia, finance, government, and research networks
  • You’ll have access to our specialist grant writing expertise – who can work work with you to craft top quality grant applications.
  • Access to our teams wealth of industrial and academic expertise – specifically in drug discovery, complex cell models, assay development, biomarker identification, and validation.
  • You’ll have supported access, with specialist expertise, to cutting edge technologies including multi-omics capabilities, mass spec quantitation, mass spec imaging, and organ-on-a-chip capabilities.
  • Access to expert translating analytical methodologies – that are sensitive, specific, and robust for clinical utility.
  • Our Informatics team have deep expertise in natural language processing, data analysis, machine learning, cheminformatics, and bioinformatics.
  • We’ll provide access to information not readily available elsewhere – around target validation, drug target interaction, and downstream consequences of engagement.
  • We can help unlock access to appropriately consented patient Samples & Data.
  • We’ll give you access to a network of clinical, academic, and industry experts via Virtual R&D.
Glowing Bulb On Among Bulbs Off